Contrary to these results, Tada et al. (2019) recently demonstrated that reducing HIF-1α expression using the prostacyclin analog ONO-1301-MS increased the survival rate and motor functions in an animal model of ALS. The gene discussed is HIF1A; the disease is amyotrophic lateral sclerosis.